文献库，生知库 | 链接生命科学的每一步

日期影响因子

Two diverse carriers are better than one: A case study in α-particle therapy for prostate specific membrane antigen-expressing prostate cancers

两种不同的载体比一种更好：α粒子疗法治疗表达前列腺特异性膜抗原的前列腺癌的案例研究

期刊:Bioengineering & Translational Medicine

影响因子:5.7

doi:10.1002/btm2.10266

Salerno, Dominick; Howe, Alaina; Bhatavdekar, Omkar; Josefsson, Anders; Pacheco-Torres, Jesus; Bhujwalla, Zaver M; Gabrielson, Kathleen L; Sofou, Stavroula

发表日期：2022

文献求助收藏

The Rate of Cisplatin Dosing Affects the Resistance and Metastatic Potential of Triple Negative Breast Cancer Cells, Independent of Hypoxia

顺铂给药速率影响三阴性乳腺癌细胞的耐药性和转移潜能，且与缺氧无关。

期刊:Pharmaceutics

影响因子:5.5

doi:10.3390/pharmaceutics14102184

Bhatavdekar, Omkar; Godet, Inês; Gilkes, Daniele; Sofou, Stavroula

细胞生物学

发表日期：2022

文献求助收藏

FPT, a 2-Aminotetralin, Is a Potent Serotonin 5-HT1A, 5-HT1B, and 5-HT1D Receptor Agonist That Modulates Cortical Electroencephalogram Activity in Adult Fmr1 Knockout Mice

FPT 是一种 2-氨基四氢萘，是一种有效的血清素 5-HT1A、5-HT1B 和 5-HT1D 受体激动剂，可调节成年 Fmr1 基因敲除小鼠的皮质脑电图活动

期刊:ACS Chemical Neuroscience

影响因子:4.1

doi:10.1021/acschemneuro.2c00574

Tanishka S Saraf, Ryan P McGlynn, Omkar M Bhatavdekar, Raymond G Booth, Clinton E Canal

发表日期：2022

文献求助收藏

Spontaneous seizures in adult Fmr1 knockout mice: FVB.129P2-Pde6b(+)Tyr(c-ch)Fmr1(tm1Cgr)/J

成年Fmr1基因敲除小鼠的自发性癫痫发作：FVB.129P2-Pde6b(+)Tyr(c-ch)Fmr1(tm1Cgr)/J

期刊:Epilepsy Research

doi:10.1016/j.eplepsyres.2022.106891

Armstrong, Jessica L; Saraf, Tanishka S; Bhatavdekar, Omkar; Canal, Clinton E

发表日期：2022

文献求助收藏

Combination of Carriers with Complementary Intratumoral Microdistributions of Delivered α-Particles May Realize the Promise for (225)Ac in Large, Solid Tumors

将载体与递送的α粒子在肿瘤内互补的微分布相结合，有望实现(225)Ac在大型实体瘤中的疗效。

doi:10.2967/jnumed.121.262992

Howe, Alaina; Bhatavdekar, Omkar; Salerno, Dominick; Josefsson, Anders; Pacheco-Torres, Jesus; Bhujwalla, Zaver M; Gabrielson, Kathleen L; Sgouros, George; Sofou, Stavroula

发表日期：2022

文献求助收藏